In the field of bone health, teriparatide and abaloparatide offer new treatment pathways for osteoporosis patients. These two peptide drugs are used to treat osteoporosis, particularly suitable for patients at high risk of fractures, such as postmenopausal women. They mimic the action of parathyroid hormone, stimulating new bone formation and enhancing bone strength.
This mechanism of precisely mimicking the body's own signaling molecules is a typical example of peptide drugs' application in the medical field. While many traditional drugs work by blocking or altering biological pathways, peptide drugs often mimic the body's own signaling molecules. They have more complex structures and can precisely target specific biological pathways, making them potentially highly effective in appropriate situations. Currently, about 85 peptide drugs have received FDA approval, and they continue to expand in fields such as medicine, skincare, sports recovery, and healthy aging, demonstrating broad application prospects.
Medical professionals typically determine usage duration based on treatment goals and efficacy changes, and track effects by monitoring blood sugar, liver and kidney function, blood pressure, inflammation markers, as well as hormone levels like IGF-1 and thyroid hormones. Administration methods for peptide products include oral, nasal, injection, and topical. Healthy habits like regular exercise may enhance the benefits of certain peptides.
Meanwhile, collagen peptides, as dietary supplements, have been shown in research to potentially help improve joint comfort and function, and provide some support for body composition, muscle strength, and post-exercise recovery. The application of peptide products in bone and joint health is continuously expanding, offering more options for maintaining bone health and improving joint function.